KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Merck (MRK) Restructuring Costs (2016 - 2025)

Merck (MRK) has disclosed Restructuring Costs for 17 consecutive years, with $213.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Restructuring Costs rose 317.65% to $213.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $889.0 million, a 186.77% increase, with the full-year FY2025 number at $889.0 million, up 187.7% from a year prior.
  • Restructuring Costs was $213.0 million for Q4 2025 at Merck, up from $47.0 million in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $560.0 million in Q2 2025 to a low of $47.0 million in Q3 2025.
  • A 5-year average of $139.8 million and a median of $100.5 million in 2021 define the central range for Restructuring Costs.
  • Peak YoY movement for Restructuring Costs: plummeted 82.15% in 2022, then skyrocketed 600.0% in 2025.
  • Merck's Restructuring Costs stood at $175.0 million in 2021, then plummeted by 72.0% to $49.0 million in 2022, then soared by 420.41% to $255.0 million in 2023, then plummeted by 80.0% to $51.0 million in 2024, then surged by 317.65% to $213.0 million in 2025.
  • Per Business Quant, the three most recent readings for MRK's Restructuring Costs are $213.0 million (Q4 2025), $47.0 million (Q3 2025), and $560.0 million (Q2 2025).